V(H) gene usage by family members affected with chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 107, Issue 3, 1999, Pages 616-624

  Pritsch, Otto ^a   Troussard, Xavier ^b   Magnac, Christian ^a   Mauro, Francesca R ^c   Davi, Frederic ^d   Payelle Brogard, Beatrice ^a   Dumas, Gerard ^a   Pulik, Marc ^g   Clerget, Françoise ^g   Mandelli, Franco ^c   Chiorazzi, Nicholas ^e   Schroeder Jr , Harry W ^f   Leporrier, Michel ^b   Dighiero, Guillaume ^a  

^a INSTITUT PASTEUR   (France)

^b Service d'Hématologie Clínique   (France)

^c Policlinico La Sapienza   (Italy)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e INSERM   (France)

^f NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^g NONE

Author keywords

Familial chronic lymphocytic leukaemia; V(H) genes

Indexed keywords

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; AMINO ACID SEQUENCE; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MUTATION;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; FEMALE; GENES, IMMUNOGLOBULIN; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 0033258062     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01757.x     Document Type: Article

References (36)

1. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Jacquillat, C., Bolvin, P., Lesty, C., Duault, M.T., Monconduit, M., Belabbes, S. & Gremy, F. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 48, 198-206.
2. Borche, L., Lim, A., Binet, J.L. & Dighiero, G. (1990) Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood, 76, 562-569.
3. Brezinschek, H.P., Brezinschek, R.I. & Lipsky, P.E. (1995) Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. Journal of Immunology, 155, 190-202.
4. Bröker, B.M., Klajman, A., Youinou, P., Jouquan, J., Worman, C.P., Murphy, J., Mackenzie, L., Quartey-Papafio, R., Blaschek, M., Collins, P., Lal, S. & Lydyard, P.M. (1988) Chronic lymphocytic leukemia (CLL) cells secrete multispecific autoantibodies. Journal of Autoimmunity, 1, 469-481.
5. Catovsky, D. (1997) The search for genetics clues in chronic lymphocytic leukemia. Hematology and Cell Therapy, 39, S5-S11.
6. H genes are inherently susceptible to amino acid replacement. Immunology Today, 15, 367-373.
7. Conley, C.L., Misiti, J. & Laster, A.J. (1980) Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine, 59, 323-334.
8. H repertoire. Immunology Today, 16, 237-242.
9. Corbett, S.J., Tomlinson, I.M., Sonnhammer, L., Buck, D. & Winter, G. (1997) Sequence of the human immunoglobulin diversity (D) segment locus; a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, 'minor' D segments or D-D recombination. Journal of Molecular Biology, 270, 587-597.
10. Dameshek, W. (1967) Chronic lymphocytic leukemia an accumulative disease of immunologically incompetent lymphocytes. Blood, 29, 566-584.
11. Deane, M. & Norton, J.D. (1990) Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. European Journal of Immunology, 20, 2209-2217.
12. Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C., Binet, J.L., the French Cooperative Group on CLL (1991) B-cell chronic lymphocytic leukemia: present status and future directions. Blood, 78, 1901-1914.
13. Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Allen, S.L., Schulman, P., Vinciguerra, V.R., Rai, K., Rassenti, L., Kipps, T.J., Dighiero, C., Schroeder, H.W., Ferrarini, M. & Chiorazzi, N. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. Journal of Clinical Investigation, 102, 1515-1525.
14. Finch, S.C. & Linet, M.S. (1992) Chronic leukaemias. Baillieres Clinical Haematology, 5, 27-56.
15. Galton, D.A.G. (1966) The pathogenesis of chronic lymphocytic leukemia. Canadian Medical Association Journal, 94, 1005-1010.
16. Hakim, I., Amariglio, N., Brok-Simoni, F., Berkowitz, M., Rosner, E., Kneller, A., Hulu, N., Ramot, B., Ben-Bassat, I., Silverman, G.J. & Rechavi, G. (1995) Preferred usage of specific immunoglobulin gene segments in chronic lymphocytic leukaemia cells of three HLA-identical sisters. British Journal of Haematology, 91, 915-917.
17. + chronic lymphocytic leukemia B cells. Journal of Experimental Medicine, 181, 1507-1517.
18. Horwitz, M., Goode, E.L. & Jarvik, G.P. (1996) Anticipation in familial leukemia. American Journal of Human Genetics, 59, 990-998.
19. Huang, C. & Stollar, B.D. (1993) A majority of IgH cDNA of normal human adult blood lymphocytes resembles cDNA for fetal Ig and natural autoantibodies. Journal of Immunology, 151, 5290-5300.
20. Huang, S.C., Jiang, R., Glas, A.M. & Milner, E.C. (1996) Nonstochastic utilization of Ig V region genes in unselected human peripheral B cells. Molecular Immunology, 33, 553-560.
21. H family preferentially rearranged in immature B-cell tumours. Nature, 331, 446-449.
22. H1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. Journal of Immunoloigy, 158, 235-246.
23. Kipps, T.J., Tomhave, E., Pratt, L.F., Duffy, S., Chen, P.P. & Carson, D.A. (1989) Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 86, 5913-5919.
24. Kirkham, P.M. & Schroeder, H.W. (1994) Antibody structure and the evolution of immunoglobulin V gene segments. Seminars in Immunology, 6, 347-360.
25. Linet, M.S., Van Natta, M.L., Brookmeyer, R., Khoury, M.J., McCaffrey, L.D., Humphrey, R.L. & Szklo, M. (1989) Familial cancer history and chronic lymphocytic leukemia: a case - control study. American Journal of Epidemiology, 130, 655-664.
26. Pascual, V. & Capra, J.D. (1991) B-cell superantigens? Current Biology, 1, 315-317.
27. + B-cell chronic lymphocytic leukemia and displaying autoantibody activity. Blood, 82, 3103-3112.
28. Schroeder, H.W. & Dighiero, G. (1994) The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunology Today, 15, 288-294.
29. Schweitzer, M., Melief, C.J.M. & Ploem, J.E. (1973) Chronic lymphocytic leukaemia in five siblings. Scandinavian Journal of Haematology, 11, 97-105.
30. Shen, A., Humphries, C., Tucker, P. & Blattner, F. (1987) Human heavy-chain variable region gene family nonrandomly rearranged in familial chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 84, 8563-8567.
31. H gene in the expressed human B cell repertoire. Journal of Experimental Medicine, 177, 409-418.
32. Sthoeger, Z.M., Wakai, M., Tse, D.B., Vinciguerra, V.P., Allen, S.L., Budman, D.R., Lichtman, S.M., Schulman, P., Weiselberg, L.R. & Chiorazzi, N. (1989) Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. Journal of Experimental Medicine, 169, 255-268.
33. Tonegawa, S. (1983) Somatic generation of antibody diversity. Nature, 302, 575-581.
34. Troussard, X., Pritsch, O., Macro, M., Dumas, G., Magnac, C., Clerget, F., Schroeder, H.W., Leporrier, M. & Dighiero, G. (1996) Do B-cell superantigens play a role in CLL leukemogenesis? (Abstract). Blood, 88, (Suppl.), 239a.
35. + B-CLL cells expresses virtually identical antigen receptors that bind similar peptides: evidence for antigen-selection in the leukemogenic process. (Abstract). Blood, 92, (Suppl.), 1784a.
36. Zouali, M. (1995) B-cell superantigens: implications for selection of the human antibody repertoire. Immunology Today, 16, 399-405.